Oral low molecular weight heparin delivery by microparticles from complex coacervation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 67, Issue 3, 2007, Pages 632-638

  Lamprecht, Alf ^a,b   Ubrich, Nathalie ^b   Maincent, Philippe ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Complex coacervation; Gelatin; Low molecular weight heparin; Microparticles; Oral absorption; Tinzaparin

Indexed keywords

GELATIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN CACO 2; COACERVATION; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG TRANSPORT; ENCAPSULATION; HUMAN; HUMAN CELL; MALE; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; RABBIT;

ANIMALS; ANTICOAGULANTS; CACO-2 CELLS; CELL ADHESION; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GELATIN; GUM ARABIC; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; RABBITS; SPECTROMETRY, FLUORESCENCE;

EID: 35348863173     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.04.004     Document Type: Article

References (23)

1. Harrison L., McGinnis J., Crowther M., Ginsberg J., and Hirsh J. Assessment of outpatient treatment of deep vein thrombosis with low molecular weight heparin. Arch. Intern. Med. 158 (1998) 2001-2003
2. Hyers T.M., Agnelli G., Hull R., Weg J.G., Morris T.A., Samama M., and Tapson V. Antithrombotic therapy for venous thromboembolic disease. Chest 114 (1998) 561S-578S
3. Ageno W. Treatment of venous thromboembolism. Thromb. Res. 97 (2000) V63-V72
4. DalPozzo A., Acquasaliente M., and Geron M.R. New heparin complexes active by intestinal absorption, I : multiple ion pairs with basic organic compounds. Thromb. Res. 56 (1989) 119-124
5. Leone-Bay A., Paton D., Variano B., Leipold H., Rivera T., Miura-Fraboni J., Baughman R.A., and Santiago N. Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium. J. Control Release 50 (1998) 41-49
6. S. Steiner, R. Rosen, Delivery system for pharmacological agents encapsulated with proteinoids. US patent 4925673 (1990).
7. Gonze M.D., Salartash K., Sternbergh III W.C., Baughman R.A., Leone-Bay A., and Money S.R. Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis. Circulation 101 (2000) 2658-2661
8. Baughman R.A., Kapoor S.C., Agarwal R.K., Kisicki J., Catella-Lawson F., and FitzGerald G.A. Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans. Circulation 98 (1998) 1610-1615
9. Jiao Y., Ubrich N., Hoffart V., Marchand-Arvier M., Vigneron C., Hoffman M., and Maincent P. Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits. J. Pharm. Sci. 91 (2002) 1-9
10. Jiao Y., Ubrich N., Marchand-Arvier M., Vigneron C., Hoffman M., Lecompte T., and Maincent P. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation 105 (2002) 230-235
11. Luzzi L.A., and Gerraughty R.J. Effects of selected variables on the microencapsulation of solids. J. Pharm. Sci. 56 (1967) 634-638
12. Lamprecht A., Schäfer U., and Lehr C.M. Influences of process parameters on microparticle preparation as carrier system for omega-3 unsaturated fatty acid ethyl ester used in supplementary nutrition. J. Microencapsul. 18 (2001) 347-357
13. Tsung M., and Burgess D.J. Preparation and stabilization of heparin/gelatin complex coacervate microcapsules. J. Pharm. Sci. 86 (1997) 603-607
14. Hoffart V., Ubrich N., Lamprecht A., Bachelier K., Vigneron C., Lecompte T., Hoffman M., and Maincent P. Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers. Drug Deliv. 10 (2003) 1-7
15. Lamprecht A., Koenig P., Ubrich N., Maincent P., and Neumann D. Low molecular weight heparin nanoparticles: mucoadhesion and behavior in Caco-2 cells. Nanotechnology 17 (2006) 3673-3680
16. White R.H. Hematology. Am. Soc. Hematol. (2001) Ed. Program book
17. Luzzi L.A., and Gerraughty R.J. Effects of selected variables on the extractability of oils from coacervate capsules. J. Pharm. Sci. 53 (1964) 429-431
18. Lamprecht A., Schäfer U., and Lehr C.M. Characterisation of microcapsules by confocal laser scanning microscopy: analysis of structure, capsule wall composition and of encapsulation rate. Eur. J. Pharm. Biopharm. 49 (2000) 1-9
19. Nissan A., Ziv E., Kidron M., Bar-On H., Friedman G., Hyam E., and Eldor A. Intestinal absorption of low molecular weight heparin in animals and human subjects. Haemostasis 30 (2000) 225-232
20. Aprahamian M., Michel C., Humbert W., Devissaguet J.P., and Damge C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell 61 (1987) 69-76
21. Jani P., Halbert G.W., Langridge J., and Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41 (1989) 809-812
22. Jepson M.A., Simmons N.L., O'Hagan D.T., and Hirst B.H. Comparison of poly(dl-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M-cells. J. Drug Target 1 (1993) 245-249
23. Thanou M., Florea B.I., Langemeyer M.W., Verhoef J.C., and Junginger H.E. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm. Res. 17 (2000) 27-31